Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2004

Content (15 Articles)

Genetic Variants of the Sulfotransferase 1A1 and Breast Cancer Risk

Uwe Langsenlehner, Peter Krippl, Wilfried Renner, Babak Yazdani-Biuki, Tanja Eder, Gerald Wolf, Thomas C. Wascher, Bernhard Paulweber, Werner Weitzer, Hellmut Samonigg

Mutations of the p53 Gene and Loss of Heterozygosity at Chromosome 17p13.1 are Associated with Increased Survivin Expression in Breast Cancer

Naoki Tsuji, Kaori Furuse, Koichi Asanuma, Momoko Furuya, Kei Kondoh, Chinatsu Kamagata, Masateru Sasaki, Daisuke Kobayashi, Atsuhito Yagihashi, Hiroshi Takahashi, Naoki Watanabe

Overexpression of Bcl-xL in Human Breast Cancer Cells Enhances Organ-Selective Lymph Node Metastasis

Laura España, Yolanda Fernández, Nuria Rubio, Angels Torregrosa, Jeronimo Blanco, Angels Sierra

Quality of Life of Breast Cancer Survivors After a Recurrence: A Follow-Up Study

Sindy Oh, Lara Heflin, Beth E. Meyerowitz, Katherine A. Desmond, Julia H. Rowland, Patricia A. Ganz

Failure of High Risk Women to Produce Nipple Aspirate Fluid Does Not Exclude Detection of Cytologic Atypia in Random Periareolar Fine Needle Aspiration Specimens

Priyanka Sharma, Jennifer R. Klemp, Marie Simonsen, Chezna M. Welsko, Carola M. Zalles, Bruce F. Kimler, Carol J. Fabian

Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow

C. Schindlbeck, W. Janni, N. Shabani, B. Rack, B. Gerber, M. Schmitt, N. Harbeck, H. Sommer, S. Braun, K. Friese

Does Subjective Burden of Early Breast Cancer and its Treatment Affect Immune Measures During Adjuvant Therapy?

Marzio E.E. Sabbioni, Jürg Bernhard, Hans-Peter Siegrist, Shu-Fang Hsu Schmitz, Monica Castiglione Gertsch, Beat Thürlimann, Hervé Bonnefoi, Lucien Perey, Richard Herrmann, Aron Goldhirsch, Christoph Hürny

EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines

James M. Rae, Joshua O. Scheys, Kim M. Clark, Robert B. Chadwick, Michael C. Kiefer, Marc E. Lippman

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine